Prudential Financial Inc Pacira Bio Sciences, Inc. Transaction History

Prudential Financial Inc

  • $80 Billion
  • Q3 2025

A detailed history of Prudential Financial Inc transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 149,448 shares of PCRX stock, worth $3.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
149,448
Previous 76,728 94.78%
Holding current value
$3.55 Million
Previous $1.83 Million 110.09%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
BUY
$21.09 - $27.22 $1.53 Million - $1.98 Million
72,720 Added 94.78%
149,448 $3.85 Million
Q2 2025

Aug 12, 2025
BUY
$22.91 - $27.14 $57,275 - $67,850
2,500 Added 3.37%
76,728 $1.83 Million
Q1 2025

May 13, 2025
SELL
$18.33 - $27.25 $3.3 Million - $4.9 Million
-179,940 Reduced 70.8%
74,228 $1.84 Million
Q4 2024

Feb 11, 2025
SELL
$15.3 - $20.33 $2.91 Million - $3.87 Million
-190,286 Reduced 42.81%
254,168 $4.79 Million
Q3 2024

Nov 13, 2024
BUY
$11.7 - $28.46 $2.78 Million - $6.76 Million
237,629 Added 114.89%
444,454 $6.69 Million
Q2 2024

Aug 13, 2024
BUY
$25.5 - $31.51 $3.19 Million - $3.94 Million
124,951 Added 152.61%
206,825 $5.92 Million
Q1 2024

May 14, 2024
BUY
$27.7 - $35.48 $616,851 - $790,104
22,269 Added 37.36%
81,874 $2.39 Million
Q4 2023

Feb 13, 2024
BUY
$26.32 - $34.31 $119,203 - $155,389
4,529 Added 8.22%
59,605 $2.01 Million
Q3 2023

Nov 13, 2023
SELL
$30.68 - $40.09 $74,337 - $97,138
-2,423 Reduced 4.21%
55,076 $1.69 Million
Q2 2023

Aug 11, 2023
BUY
$36.12 - $47.5 $435,426 - $572,612
12,055 Added 26.53%
57,499 $2.3 Million
Q1 2023

May 12, 2023
SELL
$35.53 - $43.38 $40,930 - $49,973
-1,152 Reduced 2.47%
45,444 $1.85 Million
Q4 2022

Feb 14, 2023
SELL
$38.19 - $57.45 $85,927 - $129,262
-2,250 Reduced 4.61%
46,596 $0
Q3 2022

Nov 04, 2022
BUY
$51.24 - $58.89 $4,714 - $5,417
92 Added 0.19%
48,846 $2.65 Million
Q2 2022

Aug 15, 2022
SELL
$51.49 - $81.64 $4,273 - $6,776
-83 Reduced 0.17%
48,754 $2.86 Million
Q1 2022

May 13, 2022
SELL
$60.03 - $76.49 $27,973 - $35,644
-466 Reduced 0.95%
48,837 $3.73 Million
Q4 2021

Feb 14, 2022
BUY
$47.97 - $62.21 $53,678 - $69,612
1,119 Added 2.32%
49,303 $2.78 Million
Q3 2021

Nov 15, 2021
SELL
$54.64 - $61.3 $17,867 - $20,045
-327 Reduced 0.67%
48,184 $2.7 Million
Q2 2021

Aug 16, 2021
SELL
$59.18 - $69.99 $151,559 - $179,244
-2,561 Reduced 5.01%
48,511 $2.94 Million
Q1 2021

May 12, 2021
BUY
$59.31 - $78.82 $40,093 - $53,282
676 Added 1.34%
51,072 $3.58 Million
Q4 2020

Feb 16, 2021
BUY
$50.47 - $66.26 $2.53 Million - $3.32 Million
50,166 Added 21811.3%
50,396 $3.02 Million
Q3 2020

Aug 05, 2021
SELL
$51.97 - $63.0 $2.59 Million - $3.14 Million
-49,887 Reduced 99.54%
230 $14,000
Q3 2020

Nov 16, 2020
SELL
$51.97 - $63.0 $5.77 Million - $6.99 Million
-110,950 Reduced 68.88%
50,117 $3.01 Million
Q2 2020

Aug 12, 2020
BUY
$30.8 - $52.47 $401,324 - $683,684
13,030 Added 8.8%
161,067 $8.45 Million
Q1 2020

May 12, 2020
SELL
$28.4 - $50.7 $188,519 - $336,546
-6,638 Reduced 4.29%
148,037 $4.96 Million
Q4 2019

Feb 11, 2020
BUY
$36.31 - $46.83 $143,460 - $185,025
3,951 Added 2.62%
154,675 $7.01 Million
Q3 2019

Nov 13, 2019
BUY
$35.66 - $44.99 $5.2 Million - $6.56 Million
145,792 Added 2956.04%
150,724 $5.74 Million
Q2 2019

Aug 08, 2019
SELL
$36.57 - $47.97 $2.4 Million - $3.15 Million
-65,577 Reduced 93.01%
4,932 $0
Q1 2019

May 15, 2019
SELL
$36.47 - $42.17 $119,621 - $138,317
-3,280 Reduced 4.45%
70,509 $0
Q4 2018

Feb 07, 2019
SELL
$41.31 - $52.16 $185,688 - $234,459
-4,495 Reduced 5.74%
73,789 $3.17 Million
Q3 2018

Nov 07, 2018
BUY
$32.85 - $52.0 $2.57 Million - $4.07 Million
78,284 New
78,284 $0

Others Institutions Holding PCRX

# of Institutions
261
Shares Held
48.9M
Call Options Held
118K
Put Options Held
63.7K
View Full List

About Pacira BioSciences, Inc.

PCRX Quotes by TradingView
  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $1.09B
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email